Staar Surgical (STAA) Cash from Financing Activities (2010 - 2026)

Staar Surgical's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$1.7 million for Q2 2026.

• Quarterly Cash from Financing Activities fell 78.59% year-over-year to -$1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$5.3 million (down 836.11% YoY) and the FY2026 annual result came in at -$4.6 million, down 179.58% from the prior year.
• Cash from Financing Activities was -$1.7 million for Q2 2026 at Staar Surgical, down from -$50000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $7.1 million in Q3 2023 and bottomed at -$4.5 million in Q2 2025.
• A 5-year average of $893411.8 and a median of $367000.0 in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 398.02% — and 2025, when it tumbled 2885.28%.
• Staar Surgical's Cash from Financing Activities stood at $202000.0 in 2022, then jumped by 81.68% to $367000.0 in 2023, then slumped by 129.97% to -$110000.0 in 2024, then jumped by 993.64% to $983000.0 in 2025, then tumbled by 272.23% to -$1.7 million in 2026.
• Business Quant data shows STAA's Cash from Financing Activities at -$1.7 million in Q2 2026, -$50000.0 in Q1 2026, and $983000.0 in Q3 2025.